{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:25:32Z","timestamp":1770816332314,"version":"3.50.1"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009532","name":"Ministerstvo Vnitra \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["VI20172020056, VG20122015075"],"award-info":[{"award-number":["VI20172020056, VG20122015075"]}],"id":[{"id":"10.13039\/100009532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["PROGRES Q35, SVV 260388"],"award-info":[{"award-number":["PROGRES Q35, SVV 260388"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NIMH-CZ, 00023752"],"award-info":[{"award-number":["NIMH-CZ, 00023752"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ED 2.1.00\/03.0078"],"award-info":[{"award-number":["ED 2.1.00\/03.0078"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["LO1611 under NPU I program"],"award-info":[{"award-number":["LO1611 under NPU I program"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2017.00306","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T08:38:23Z","timestamp":1515573503000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats"],"prefix":"10.3389","volume":"8","author":[{"given":"Kl\u00e1ra","family":"\u0160\u00edchov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Pinterov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"\u017didkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel R.","family":"Horsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Lhotkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krist\u00fdna","family":"\u0160tefkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u010cestm\u00edr","family":"Vejmola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libor","family":"Uttl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Bal\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kucha\u0159","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"P\u00e1len\u00ed\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/02791072.2011.566500","article-title":"Legally tripping: a qualitative profile of salvia divinorum use among young adults","volume":"43","author":"Kelly","year":"2011","journal-title":"J Psychoactive Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3109\/15563650.2011.615318","article-title":"Clinical toxicology of newer recreational drugs (vol 49, pg 705, 2011)","volume":"49","author":"Hill","year":"2011","journal-title":"Clin Toxicol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2012.12.006","article-title":"Neurochemical profiles of some novel psychoactive substances","volume":"700","author":"Iversen","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.drugalcdep.2011.02.011","article-title":"A web-based survey on mephedrone","volume":"118","author":"Carhart-Harris","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"B5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00213-011-2529-4","article-title":"Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users","volume":"220","author":"Brunt","year":"2012","journal-title":"Psychopharmacology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00213-012-2855-1","article-title":"Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats","volume":"225","author":"Varner","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1111\/bph.12628","article-title":"The preclinical pharmacology of mephedrone; not just MDMA by another name","volume":"171","author":"Green","year":"2014","journal-title":"Br J Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1570159X13666141210225009","article-title":"Cathinone neurotoxicity (\u201cThe \u201c3Ms\u201d)","volume":"13","author":"Karch","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00213-010-2070-x","article-title":"Mephedrone (4-methylmethcathinone; \u2018meow meow\u2019): chemical, pharmacological and clinical issues","volume":"214","author":"Schifano","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1177\/0269881116653106","article-title":"Mephedrone and 3,4-methylenedioxy-methamphetamine: comparative psychobiological effects as reported by recreational polydrug users","volume":"30","author":"Jones","year":"2016","journal-title":"J Psychopharmacol"},{"key":"B11","first-page":"313","article-title":"Clinical pharmacology of the synthetic cathinone mephedrone","volume-title":"Neuropharmacology of New Psychoactive Substances (NPS): The Science Behind the Headlines","author":"Papaseit","year":"2017"},{"key":"B12","volume-title":"Europol\u2013EMCDDA Joint Report on a New Psychoactive Substance: 4-Methylmethcathinone (Mephedrone)","year":"2010"},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2807\/1560-7917.ES.2016.21.19.30225","article-title":"Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection?","volume":"21","author":"Hope","year":"2016","journal-title":"Euro Surveill"},{"key":"B14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jat\/34.3.162","article-title":"Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin","volume":"34","author":"Dickson","year":"2010","journal-title":"J Anal Toxicol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/JCP.0b013e318266c70c","article-title":"Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, \u201cmeow meow\u201d) in the United Kingdom","volume":"32","author":"Schifano","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/hup.2423","article-title":"Deaths of individuals aged 16-24 years in the UK after using mephedrone","volume":"30","author":"Loi","year":"2015","journal-title":"Hum Psychopharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S0140-6736(16)30258-6","article-title":"Mephedrone use is increasing in London","volume":"387","author":"Hockenhull","year":"2016","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pnpbp.2012.04.020","article-title":"Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity","volume":"39","author":"Wood","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hup.2610","article-title":"The effects and toxicity of cathinones from the users\u2019 perspectives: a qualitative study","volume":"32","author":"Assi","year":"2017","journal-title":"Hum Psychopharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"w14043","DOI":"10.4414\/smw.2015.14043","article-title":"Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling","volume":"145","author":"Liechti","year":"2015","journal-title":"Swiss Med Wkly"},{"key":"B22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2015.03.004","article-title":"The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter","volume":"755","author":"Pifl","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","article-title":"Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats","volume":"164","author":"Kehr","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/qjmed\/hcq134","article-title":"Mephedrone use and associated adverse effects in school and college\/university students before the UK legislation change","volume":"103","author":"Dargan","year":"2010","journal-title":"QJM"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/j.1360-0443.2011.03502.x","article-title":"Mephedrone: use, subjective effects and health risks","volume":"106","author":"Winstock","year":"2011","journal-title":"Addiction"},{"key":"B27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1124\/jpet.111.184119","article-title":"4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse","volume":"339","author":"Hadlock","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugalcdep.2012.04.021","article-title":"Mephedrone (\u2019bath salt\u2019) elicits conditioned place preference and dopamine-sensitive motor activation","volume":"126","author":"Lisek","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"B29","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/adb.12038","article-title":"Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats","volume":"18","author":"Aarde","year":"2013","journal-title":"Addict Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1111\/bph.13547","article-title":"Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters","volume":"173","author":"Mayer","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.euroneuro.2012.09.005","article-title":"Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat","volume":"23","author":"Shortall","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"B32","article-title":"Measurement of startle response, prepulse inhibition, and habituation","volume-title":"Current Protocols in Neuroscience","author":"Geyer","year":"2001"},{"key":"B33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s002130050887","article-title":"Effects of sustained cocaine exposure on sensorimotor gating of startle in rats","volume":"142","author":"Martinez","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbr.2005.01.002","article-title":"Clozapine attenuates the locomotor sensitisation and the prepulse inhibition deficit induced by a repeated oral administration of Catha edulis extract and cathinone in rats","volume":"160","author":"Banjaw","year":"2005","journal-title":"Behav Brain Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00008877-200503000-00009","article-title":"Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA)","volume":"16","author":"Bubenikova","year":"2005","journal-title":"Behav Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.4049\/jimmunol.0901355","article-title":"5-Lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity","volume":"184","author":"Horrillo","year":"2010","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00213-012-2797-7","article-title":"Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats","volume":"225","author":"Palenicek","year":"2013","journal-title":"Psychopharmacology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pnpbp.2016.04.004","article-title":"Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): pharmacokinetics, behaviour, thermoregulation and LD50 in rats","volume":"69","author":"Palenicek","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fpsyt.2017.00232","article-title":"Pharmacokinetic, ambulatory, and hyperthermic effects of 3,4-methylenedioxy-N-methylcathinone (methylone) in rats","volume":"8","author":"\u0160tefkov\u00e1","year":"2017","journal-title":"Front Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/adb.12283","article-title":"Contribution of serotonin and dopamine to changes in core body temperature and locomotor activity in rats following repeated administration of mephedrone","volume":"21","author":"Shortall","year":"2015","journal-title":"Addict Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.pbb.2010.12.011","article-title":"Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats","volume":"98","author":"Palenicek","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.08.012","article-title":"MDMA and temperature: a review of the thermal effects of \u2018ecstasy\u2019 in humans","volume":"121","author":"Parrott","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"B43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/0960327110370984","article-title":"Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions","volume":"30","author":"Halpern","year":"2011","journal-title":"Hum Exp Toxicol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.physbeh.2005.08.043","article-title":"Increased sensitivity to the acute effects of MDMA (\u201cecstasy\u201d) in female rats","volume":"86","author":"Palenicek","year":"2005","journal-title":"Physiol Behav"},{"key":"B45","first-page":"781","article-title":"An analysis of spontaneous behavior following acute MDMA treatment in male and female rats","volume":"28","author":"Palenicek","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"key":"B46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.brainresbull.2016.05.002","article-title":"Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue \u2013 behavioural, pharmacokinetic and metabolic studies in the Wistar rat","volume":"126","author":"Horsley","year":"2016","journal-title":"Brain Res Bull"},{"key":"B48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00213-013-3108-7","article-title":"Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics","volume":"229","author":"Martinez-Clemente","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.toxlet.2008.01.017","article-title":"Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration","volume":"178","author":"Rohanova","year":"2008","journal-title":"Toxicol Lett"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00216-015-9221-1","article-title":"Salting-out-assisted liquid-liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples","volume":"408","author":"Hajkova","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0165-0173(83)90038-3","article-title":"The role of dopamine in locomotor activity and learning","volume":"287","author":"Beninger","year":"1983","journal-title":"Brain Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0003-3472(73)80065-X","article-title":"Tests for emotionality in rats and mice: a review","volume":"21","author":"Archer","year":"1973","journal-title":"Anim Behav"},{"key":"B53","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol Bull"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s11064-015-1566-5","article-title":"Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models","volume":"40","author":"Budzynska","year":"2015","journal-title":"Neurochem Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.pbb.2012.10.006","article-title":"Long-term cognitive and neurochemical effects of \u201cbath salt\u201d designer drugs methylone and mephedrone","volume":"103","author":"Den Hollander","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"B56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/0269881113490325","article-title":"High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine","volume":"27","author":"Motbey","year":"2013","journal-title":"J Psychopharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bbr.2007.07.036","article-title":"Perinatal exposure to 5-metoxytryptamine, behavioural-stress reactivity and functional response of 5-HT1A receptors in the adolescent rat","volume":"186","author":"Cannizzaro","year":"2008","journal-title":"Behav Brain Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1472-8206.2009.00772.x","article-title":"Relations between open-field, elevated plus-maze, and emergence tests in C57BL\/6J and BALB\/c mice injected with GABA- and 5HT-anxiolytic agents","volume":"24","author":"Lalonde","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00213-007-0926-5","article-title":"Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose","volume":"196","author":"Palenicek","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.pnpbp.2010.02.008","article-title":"Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition","volume":"34","author":"Palenicek","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/FBP.0000000000000198","article-title":"Sex differences and serotonergic mechanisms in the behavioural effects of psilocin","volume":"27","author":"Tyls","year":"2016","journal-title":"Behav Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF02245609","article-title":"5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats","volume":"124","author":"Kehne","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF02245610","article-title":"5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats","volume":"124","author":"Padich","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"B66","first-page":"917","article-title":"The pharmacology and toxicology of \u201cecstasy\u201d (MDMA) and related drugs","volume":"165","author":"Kalant","year":"2001","journal-title":"Can Med Assoc J"},{"key":"B67","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/sj.bjp.0706318","article-title":"Studies on the effect of MDMA (\u2018ecstasy\u2019) on the body temperature of rats housed at different ambient room temperatures","volume":"146","author":"Green","year":"2005","journal-title":"Br J Pharmacol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2017.00306\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T15:22:29Z","timestamp":1526397749000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2017.00306\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":67,"alternative-id":["10.3389\/fpsyt.2017.00306"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2017.00306","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"article-number":"306"}}